Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

Author: Benzinga Newsdesk | November 10, 2023 07:27am

Wells Fargo analyst Derek Archila upgrades Celldex Therapeutics (NASDAQ:CLDX) from Underweight to Equal-Weight and announces $27 price target.

Posted In: CLDX